Publication | Closed Access

Population pharmacokinetics of docetaxel during phase I studies using nonlinear mixed-effect modeling and nonparametric maximum-likelihood estimation

Pharmacokinetic ModelingNonlinear Mixed-effect ModelingMedicineBiostatisticsPharmacotherapyPopulation PharmacokineticsPharmacodynamic ModelingPharmacologyPhysiologically-based Pharmacokinetic ModelingPharmacokineticsNonparametric Maximum-likelihood EstimationDrug Discovery